My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

1.080 -0.010 (-0.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,334
Open 1.120
Bid (Size) 1.060 (4)
Ask (Size) 1.070 (42)
Prev. Close 1.090
Today's Range 1.050 - 1.130
52wk Range 0.2801 - 1.280
Shares Outstanding 30,213,876
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
From Cosmos Health Inc.
Via GlobeNewswire

Performance

YTD
+57.4%
+57.4%
1 Month
+34.5%
+34.5%
3 Month
+153.0%
+153.0%
6 Month
+139.5%
+139.5%
1 Year
+24.1%
+24.1%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Keep an eye on the top gainers and losers in Friday's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
From Cosmos Health Inc.
Via GlobeNewswire
Ethereum Treasury Strategy Fuels Cosmos Health's $300 Million Financing Deal—Stock Surges 31%
Via Benzinga
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
From Cosmos Health Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
From Cosmos Health Inc.
Via GlobeNewswire
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves
Via Stocktwits
Topics Economy Government
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
From Cosmos Health Inc.
Via GlobeNewswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
Via ACCESS Newswire
EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency
Via Benzinga
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
Via ACCESS Newswire
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
Via ACCESS Newswire

Frequently Asked Questions

Is Cosmos Health Inc. - Common Stock publicly traded?
Yes, Cosmos Health Inc. - Common Stock is publicly traded.
What exchange does Cosmos Health Inc. - Common Stock trade on?
Cosmos Health Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cosmos Health Inc. - Common Stock?
The ticker symbol for Cosmos Health Inc. - Common Stock is COSM on the Nasdaq Stock Market
What is the current price of Cosmos Health Inc. - Common Stock?
The current price of Cosmos Health Inc. - Common Stock is 1.080
When was Cosmos Health Inc. - Common Stock last traded?
The last trade of Cosmos Health Inc. - Common Stock was at 09/26/25 04:00 PM ET
What is the market capitalization of Cosmos Health Inc. - Common Stock?
The market capitalization of Cosmos Health Inc. - Common Stock is 32.63M
How many shares of Cosmos Health Inc. - Common Stock are outstanding?
Cosmos Health Inc. - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.